5. Conclusion
The current study found that CSO might improve NAFLD via glycemic
indices, inflammation, ME, and oxidant/antioxidant biomarkers
modulation. CSO as one of the richest dietary sources of OM3FA can be
recommended as a complementary therapy in NAFLD patients. Further trials
are required to confirm the positive results of CSO in NAFLD patients.